Telesat Corporation - TSAT

TSAT Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
TSAT	-8.9	7.4	-9.5	32.3	57.4	2.3	-73.7	-67.8	-83.9	-56.2
S&P 500	-1.4	-1.8	0.9	5.8	10.5	30.3	25.3	88.0	187.4	33123.3

Compare TSAT with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	TSAT
name	Telesat Corporation
price	12.04
changes percentage	-8.8569
change	-1.17
day low	12.04
day high	13.25
year high	15.02
year low	6.93
market cap	167757450
price avg 50	12.497
price avg 200	9.6197
exchange	NASDAQ
volume	13947
avg volume	44176
open	13.0016
previous close	13.21
eps	1.39
pe	8.66
earnings announcement	2024-11-14T05:00:00.000+0000
shares outstanding	13933343
timestamp	2024-11-15 18:17:50

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 60.0%

Overall Quarterly Financial Health: 41.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001845840
revenue	704161000	759169000	-7.25
gross profit	351967000	705165000	-50.09
gross profit ratio	0.5	0.93	-46.19
research and development expenses	0	65800000	-100.00
operating expenses	48120000	462716000	-89.60
interest income	67139000	23476000	185.99
interest expense	270957000	221756000	22.19
ebitda	499609000	395302000	26.39
ebitdaratio	0.71	0.69	2.86
operating income	568846000	296453000	91.88
operating income ratio	0.81	0.39	106.87
net income	157118000	-80117000	296.11
net income ratio	0.22	-0.11	311.43
eps	11.29	-6.51	273.43

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 704 million in 2023 from 759 million in 2022 representing a change of -7.25%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 352 million in 2023 from 705 million in 2022 representing a change of -50.09%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 66 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 48 million in 2023 from 463 million in 2022 representing a change of -89.6%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 500 million in 2023 from 395 million in 2022 representing a change of 26.39%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 569 million in 2023 from 296 million in 2022 representing a change of 91.88%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 157 million in 2023 from -80 million in 2022 representing a change of 296.11%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 11.29 in 2023 from 11.29 in 2022 representing a change of 273.43%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001845840
revenue	152433000	152175000	0.17
gross profit	78513000	76966000	2.01
gross profit ratio	0.52	0.51	1.84
research and development expenses	3700000	41800000	-91.15
operating expenses	36229000	11121000	225.77
interest income	20275000	21168000	-4.22
interest expense	61980000	64470000	-3.86
ebitda	97332000	105118000	-7.41
ebitdaratio	0.64	0.69	-7.52
operating income	61665000	65845000	-6.35
operating income ratio	0.4	0.43	-6.51
net income	35452000	-14762000	340.16
net income ratio	0.23	-0.1	339.75
eps	2.45	-1.08	326.85

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 152 million in 2024Q2 from 152 million in 2024Q1 representing a change of 0.17%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 79 million in 2024Q2 from 77 million in 2024Q1 representing a change of 2.01%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 97 million in 2024Q2 from 105 million in 2024Q1 representing a change of -7.41%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 35 million in 2024Q2 from -15 million in 2024Q1 representing a change of 340.16%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.45 in 2024Q2 from 2.45 in 2024Q1 representing a change of 326.85%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 4 million in 2024Q2 from 42 million in 2024Q1 representing a change of -91.15%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 36 million in 2024Q2 from 11 million in 2024Q1 representing a change of 225.77%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 62 million in 2024Q2 from 66 million in 2024Q1 representing a change of -6.35%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001845840
total assets	6274355000	6479593000	-3.17
total liabilities	3875372000	4643891000	-16.55
total equity	2398983000	1835702000	30.68
cash and cash equivalents	1423902000	1677792000	-15.13
short term investments	245187000	515000	47509.13
long term investments	7497000	10476000	-28.44
total current assets	1816441000	1788288000	1.57
total non current assets	4457914000	4691305000	-4.97
total current liabilities	137727000	171396000	-19.64
total non current liabilities	3737645000	4472495000	-16.43
common stock	51252000	46554000	10.09
retained earnings	534058000	355202000	50.35
total debt	3230358000	3850081000	-16.10

Overall Score of Annual Balance Sheet

0.8 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 6,274 million in 2023 from 6,480 million in 2022 representing a change of -3.17%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,424 million in 2023 from 1,678 million in 2022 representing a change of -15.13%. This indicates a decrease in available liquid assets.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 3,875 million in 2023 from 4,644 million in 2022 representing a change of -16.55%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 2,399 million in 2023 from 1,836 million in 2022 representing a change of 30.68%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 245 million in 2023 from 1 million in 2022 representing a change of 47509.13%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,816 million in 2023 from 1,788 million in 2022 representing a change of 1.57%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 138 million in 2023 from 171 million in 2022 representing a change of -19.64%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 51 in 2023 from 47 in 2022 representing a change of 10.09%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 534 million in 2023 from 355 million in 2022 representing a change of 50.35%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,230 million in 2023 from 3,850 million in 2022 representing a change of -16.1%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001845840
total assets	6404821000	6409854000	-0.08
total liabilities	3781784001	3964175000	-4.60
total equity	2623037000	2445679000	7.25
cash and cash equivalents	1427238000	1683347000	-15.21
short term investments	0	72952000	-100.00
long term investments	0	6683000	-100.00
total current assets	1590723000	1898132000	-16.20
total non current assets	4814098000	4511722000	6.70
total current liabilities	259507000	162422000	59.77
total non current liabilities	3522277001	3801753000	-7.35
common stock	56348000	53238000	5.84
retained earnings	567414000	523239000	8.44
total debt	3002220000	3269014000	-8.16

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 6,405 million in 2024Q2 from 6,410 million in 2024Q1 representing a change of -0.08%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,427 million in 2024Q2 from 1,683 million in 2024Q1 representing a change of -15.21%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 73 million in 2024Q1 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,591 million in 2024Q2 from 1,898 million in 2024Q1 representing a change of -16.2%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 260 million in 2024Q2 from 162 million in 2024Q1 representing a change of 59.77%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 3,782 million in 2024Q2 from 3,964 million in 2024Q1 representing a change of -4.6%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 2,623 million in 2024Q2 from 2,446 million in 2024Q1 representing a change of 7.25%. This indicates an increase in shareholders' equity.

  Common Stock: Common Stock increased to 56 in 2024Q2 from 53 in 2024Q1 representing a change of 5.84%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 567 million in 2024Q2 from 523 million in 2024Q1 representing a change of 8.44%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,002 million in 2024Q2 from 3,269 million in 2024Q1 representing a change of -8.16%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001845840
net change in cash	-8703000	228199000	-103.81
operating cash flow	169087000	228848000	-26.11
free cash flow	29581000	164271000	-81.99
capital expenditure	-139506000	-64577000	-116.03
depreciation and amortization	195762000	203734000	-3.91
deferred income tax	89596000	49929000	79.45
stock based compensation	33015000	67428000	-51.04
accounts payables	-4085000	-7068000	42.20
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-139506000	-64577000	-116.03
net cash used for investing activites	211932000	74000	286294.59
debt repayment	-346185000	-99732000	-247.12
common stock issued	27000	0	NaN
common stock repurchased	-3198000	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-354652000	-104865000	-238.20
cash at end of period	1669089000	1677792000	-0.52
accounts receivables	-24431000	2298000	-1163.14
cash at beginning of period	1677792000	1449593000	15.74

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -9 million in 2023 from 228 million in 2022 representing a change of -103.81%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 169 million in 2023 from 229 million in 2022 representing a change of -26.11%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 30 million in 2023 from 164 million in 2022 representing a change of -81.99%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 90 million in 2023 from 50 million in 2022 representing a change of 79.45%. This indicates that the company's tax liability for future periods has increased.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -140 million in 2023 from -65 million in 2022 representing a change of -116.03%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 33 million in 2023 from 67 million in 2022 representing a change of -51.04%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 4 million in 2023 from 7 million in 2022 representing a change of 42.2%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -24 million in 2023 from 2 million in 2022 representing a change of -1163.14%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001845840
operating cash flow	-9186000	75586000	-112.15
free cash flow	-21685000	56308000	-138.51
capital expenditure	-12499000	-19278000	35.16
depreciation and amortization	34452000	39218000	-12.15
deferred income tax	28546000	-1459000	2056.55
stock based compensation	6009000	5434000	10.58
accounts receivables	-13366000	12392000	-207.86
accounts payables	665000	5000	13200.00
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-12499000	-19278000	35.16
net cash used for investing activites	-199992000	-20035000	-898.21
debt repayment	-129118000	-647000	-19856.41
common stock issued	0	0	NaN
common stock repurchased	-3280000	-2116000	-55.01
dividends paid	0	0	NaN
net cash used provided by financing activities	-133517000	-2280000	-5756.01
net change in cash	-329061000	259445000	-226.83
cash at end of period	1427238000	1683347000	-15.21
cash at beginning of period	1756299000	1423902000	23.34

Overall Score of Quarterly Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -329 million in 2024Q2 from 259 million in 2024Q1 representing a change of -226.83%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to -9 million in 2024Q2 from 76 million in 2024Q1 representing a change of -112.15%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -22 million in 2024Q2 from 56 million in 2024Q1 representing a change of -138.51%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -12 million in 2024Q2 from -19 million in 2024Q1 representing a change of 35.16%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 29 million in 2024Q2 from -1 million in 2024Q1 representing a change of 2056.55%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 6 million in 2024Q2 from 5 million in 2024Q1 representing a change of 10.58%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 1 million in 2024Q2 from 0 million in 2024Q1 representing a change of 13200.0%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Accounts Receivables: Accounts Receivables decreased to -13 million in 2024Q2 from 12 million in 2024Q1 representing a change of -207.86%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	50.6	61.66	-17.95
net income per share	11.29	-6.51	273.49
operating cash flow per share	12.15	18.59	-34.64
free cash flow per share	2.13	13.34	-84.07
cash per share	119.94	136.32	-12.02
book value per share	172.38	149.11	15.61
tangible book value per share	-53.2	-111.1	52.11
shareholders equity per share	47.56	39.02	21.90
interest debt per share	249.2	330.74	-24.65
market cap	192166673.6	125034736.09	53.69
enterprise value	1998622673.6	2297323736.09	-13.00
pe ratio	1.22	-1.56	178.37
price to sales ratio	0.27	0.16	65.70
pocfratio	1.14	0.55	108.01
pfcf ratio	6.5	0.76	753.48
pb ratio	0.29	0.26	11.54
ptb ratio	0.29	0.26	11.54
ev to sales	2.84	3.03	-6.21
enterprise value over ebitda	4.0	5.81	-31.17
ev to operating cash flow	11.82	10.04	17.75
ev to free cash flow	67.56	13.98	383.12
earnings yield	0.82	-0.64	227.60
free cash flow yield	0.15	1.31	-88.28
debt to equity	4.83	8.01	-39.74
debt to assets	0.51	0.59	-14.25
net debt to ebitda	3.62	5.5	-34.20
current ratio	13.19	10.43	26.41
interest coverage	2.1	1.34	57.04
income quality	0.29	-2.86	110.15
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.17	0.2	-16.45
research and ddevelopement to revenue	0	0.09	-100.00
intangibles to total assets	0.5	0.49	1.20
capex to operating cash flow	0.83	0.28	192.38
capex to revenue	0.2	0.09	132.91
capex to depreciation	0.71	0.32	124.83
stock based compensation to revenue	0.05	0.09	-47.21
graham number	109.92	75.59	45.42
roic	0.13	0.18	-29.67
return on tangible assets	0.05	-0.02	304.94
graham net net	-153.27	-239.02	35.87
working capital	1678714000	1616892000	3.82
tangible asset value	-740376000	-1367779000	45.87
net current asset value	-2058931000	-2855603000	27.90
invested capital	6078371000	6184457000	-1.72
average receivables	62025000	77584000	-20.05
average payables	3273000	2716000	20.51
average inventory	3170000	9502500	-66.64
days sales outstanding	49.14	14.06	249.41
days payables outstanding	4.74	13.36	-64.54
days of inventory on hand	4.47	13.67	-67.28
receivables turnover	7.43	25.95	-71.38
payables turnover	77.07	27.33	181.99
inventory turnover	81.58	26.7	205.61
roe	0.24	-0.17	242.32
capex per share	10.02	5.25	91.11

• Positive

  ROE: Return on Equity (ROE) increased to 0.24 on 2023-12-31 from -0.17 on 2022-12-31, representing a change of 242.32%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 1.22 on 2023-12-31 from -1.56 on 2022-12-31, representing a change of 178.37%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 13.19 on 2023-12-31 from 10.43 on 2022-12-31, representing a change of 26.41%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 4.83 on 2023-12-31 from 8.01 on 2022-12-31, representing a change of -39.74%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
TSAT
calendar year	2024	2024	NaN
revenue per share	10.55	11.1	-4.96
net income per share	2.45	-1.08	327.86
operating cash flow per share	-0.64	5.51	-111.53
free cash flow per share	-1.5	4.11	-136.54
cash per share	98.79	128.14	-22.90
book value per share	181.57	178.43	1.76
tangible book value per share	-39.95	-53.73	25.64
shareholders equity per share	51.34	49.63	3.43
interest debt per share	212.11	243.2	-12.79
market cap	167346554.62	153263340.7	9.19
enterprise value	1742328554.62	1738930340.7	0.20
pe ratio	1.18	-2.6	145.47
price to sales ratio	1.1	1.01	9.00
pocfratio	-18.22	2.03	-998.45
pfcf ratio	-7.72	2.72	-383.52
pb ratio	0.23	0.23	0.16
ptb ratio	0.23	0.23	0.16
ev to sales	11.43	11.43	0.03
enterprise value over ebitda	17.9	16.54	8.21
ev to operating cash flow	-189.67	23.01	-924.45
ev to free cash flow	-80.35	30.88	-360.17
earnings yield	0.21	-0.1	319.95
free cash flow yield	-0.13	0.37	-135.27
debt to equity	4.05	4.81	-15.76
debt to assets	0.47	0.51	-8.09
net debt to ebitda	16.18	15.08	7.27
current ratio	6.13	11.69	-47.55
interest coverage	0.99	1.02	-2.59
income quality	-0.26	-5.12	94.94
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.19	0.17	12.00
research and ddevelopement to revenue	0.02	0.27	-91.16
intangibles to total assets	0.5	0.5	0.65
capex to operating cash flow	-1.36	0.26	-633.49
capex to revenue	0.08	0.13	-35.27
capex to depreciation	0.36	0.49	-26.20
stock based compensation to revenue	0.04	0.04	10.39
graham number	53.24	34.68	53.52
roic	0.01	0.02	-29.10
return on tangible assets	0.01	-0.0	341.89
graham net net	-159.12	-157.51	-1.02
working capital	1331216000	1735710000	-23.30
tangible asset value	-577195001	-736503000	21.63
net current asset value	-2191061001	-2066043000	-6.05
invested capital	6088811000	6189538000	-1.63
average receivables	69862000	80026500	-12.70
average payables	106786000	28080000	280.29
average inventory	0	2158500	-100.00
days sales outstanding	43.97	38.59	13.93
days payables outstanding	197.22	61.74	219.45
days of inventory on hand	0	0	NaN
receivables turnover	2.05	2.33	-12.23
payables turnover	0.46	1.46	-68.70
inventory turnover	0	0	NaN
roe	0.05	-0.02	320.29
capex per share	0.87	1.41	-38.49

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-06-30 Q2 from -0.02 on 2024-03-31 Q1, representing a change of 320.29%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 6.13 on 2024-06-30 Q2 from 11.69 on 2024-03-31 Q1, representing a change of -47.55%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 4.05 on 2024-06-30 Q2 from 4.81 on 2024-03-31 Q1, representing a change of -15.76%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 1.18 on 2024-06-30 Q2 from -2.60 on 2024-03-31 Q1, representing a change of 145.47%. Indicating an increase in the relative valuation of the company's stock.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None